Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
about
Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolismEET signaling in cancerStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerCytochrome P450-derived eicosanoids: the neglected pathway in cancer.Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer.Elevation of ω-3 Polyunsaturated Fatty Acids Attenuates PTEN-deficiency Induced Endometrial Cancer Development through Regulation of COX-2 and PGE2 ProductionMetabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo.Involvement of the arachidonic acid cytochrome P450 epoxygenase pathway in the proliferation and invasion of human multiple myeloma cells.Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.Effects of ellagic Acid on angiogenic factors in prostate cancer cells.Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.Heme Modification Contributes to the Mechanism-Based Inactivation of Human Cytochrome P450 2J2 by Two Terminal Acetylenic Compounds.
P2860
Q28245279-BD8CA722-BDE5-4FD5-86BB-1132B566C897Q28250730-86C0FBC8-E1E0-45D3-9106-71D25B9F992CQ28304230-822707F5-07BA-49C0-A6AA-14097755BA4EQ34143118-BDAE57A7-20CB-41CB-9B39-0CCBFDD6167CQ34358307-9AD187FB-1FD7-4572-B3FE-E8C2A6ACE92CQ35640659-849A6B63-B5F8-44FE-9EC7-54B492776437Q36163869-AEE1C1FE-5906-43E2-9658-C5EB49DF4CC3Q36658386-EC04D69F-CE9D-4104-ADE0-329966FD00A7Q36794225-858621FC-7E56-43C9-807A-BFC8BA0E6E34Q38100223-19F214A1-60B1-4C60-B4D0-857D89E59DF4Q39064457-6C50FF01-4A2C-4F28-A94A-92FBC81E275DQ42378504-D71B67EE-6C41-4B2A-8918-33B462753983Q49397656-C3B354BC-B39A-4495-9949-31FE6AAC2B78Q50534856-4CB83C21-BFDA-4FD8-9C9F-B49863259919
P2860
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
@ast
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
@en
type
label
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
@ast
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
@en
prefLabel
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
@ast
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.
@en
P2093
P2860
P1433
P1476
Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists
@en
P2093
Alan T Tang
Carol L Williams
Daniel M Brody
Kasem Nithipatikom
Vijaya L Manthati
William B Campbell
P2860
P304
P356
10.1111/J.1349-7006.2010.01713.X
P577
2010-08-27T00:00:00Z